Disclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu. The West Virginia Model



Similar documents
Treatment of opioid use disorders

DEPARTMENT OF PSYCHIATRY Centre Street Boston, MA 02130

Federal Response to Opioid Abuse Epidemic

Objectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.

Outcomes for Opiate Users at FRN Facilities. FRN Research Report September 2014

Financial Disclosures

Populations at risk for opioid overdose

Karol Kaltenbach, PhD Maternal Addiction Treatment Education and. Jefferson Medical College Thomas Jefferson University

Steps To Addiction Recovery Treatment

Limiting the Duration of Medication Assisted Treatment for Opioid Addiction: Will New State Policies Help or Hurt?

SUBOXONE /VIVITROL WEBINAR. Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12

Treatment of Prescription Opioid Dependence

DSM V criteria. Defining Opioid Use Disorder (Addiction)

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008

Opioid Addiction Treatment. Thomas R. Kosten, MD Professor of Psychiatry Baylor College of Medicine

Treatment of Alcoholism

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act

5317 Cherry Lawn Rd, Huntington, WV Phone: (304) Fax: (304) Welcome

TREATMENT MODALITIES. May, 2013

Prescriber Behavior, Pain Treatment and Addiction Treatment

EPIDEMIC 4.6 % OF INDIVIDUALS USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

Substance Abuse Treatment Services

Addiction Psychiatry Fellowship Rotation Goals & Objectives

National Perspectives in Medication Assisted Treatment

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:

April 23, are dependent on the nonmedical use of prescription pain medicines and heroin.

Medication is not a part of treatment.

Brief Screening, Intervention, and Referral for Alcohol and Opiate Disorders. An Effective Three-Step Process. Provider Guidelines

Recovery Outcomes for Opiate Users. FRN Research Report November 2013

Facility/Organizational Providers Approval Signatures: Available Upon Request

Buprenorphine Therapy in Addiction Treatment

Care Management Council submission date: August Contact Information

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery

MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER

The Heroin Epidemic in Adolescents and Young Adults. Marla D. Kushner, DO, FACOFP, FASAM, FSAHM AOAAM February 25, 2015

Protecting your employees, physicians and you.

Web-Based Resources. Locating Treatment

Medical and Professional Education

American Society of Addiction Medicine

Suboxone Programs: Treating Opioid Dependence in CHCs Andrew Putney, MD Medical Director SSTAR ATS and CHC, Fall River, Massachusetts

Primary care: Addictive disorders. Addiction a growing public health problem

Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study

Using Buprenorphine in an Opioid Treatment Program

4/13/15. Case 1. COWS = Clinical Opioid Withdrawal Scale. Special Populations

Oregon Health Plan - Fee-For-Service Outpatient & Opioid Replacement

Substance Use Disorder Treatment in Los Angeles: The Past, Present, and Future

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

MAT Disclosures & Consents 1 of 6. Authorization & Disclosure

Patient Information and Consent to Treatment with Buprenorphine

In 2010, approximately 8 million Americans 18 years and older were dependent on alcohol.

Magee-Womens Hospital

Triage, Assessment & Treatment

SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources

Beyond SBIRT: Integrating Addiction Medicine into Primary Care

How To Treat Anorexic Addiction With Medication Assisted Treatment

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

H-SOAP STUDY. Hospital-based Services for Opioid- and Alcohol-addicted Patients

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective

Medicine in Osteopathic Family Practice and Manipulative Treatment

Appendices to Interim Report on the Baltimore Buprenorphine Initiative. Managed Care Organization Information Pages

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK

Triage, Assessment & Treatment Methadone 101/Hospitalist Workshop

Addressing Substance Abuse in the Child Welfare Population: Lessons Learned in Vermont

Vermont s Experience A Systematic Approach to Health Care Integration Barbara Cimaglio, Deputy Commissioner. NASADAD 2015 Annual Meeting

OUTPATIENT SUBSTANCE USE DISORDER SERVICES FEE-FOR-SERVICE

Opportunities to Test Effective Opiate Treatments

Opioid/Opiate Dependent Pregnant Women

Various therapies are used in the

John R. Kasich, Governor Orman Hall, Director

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998

Testimony of The New York City Department of Health and Mental Hygiene. before the

Substance Abuse Assessment and Treatment in HIV Infection: A Case Based Discussion

Travis Baggett, MD, MPH Jessie M. Gaeta, MD Jennifer Brody, MD, MPH Boston Health Care for the Homeless Program

Opioid Treatment Services, Office-Based Opioid Treatment

MEDICAL POLICY Treatment of Opioid Dependence

ACUTE TREATMENT SERVICES (ATS) FOR SUBSTANCE USE DISORDERS LEVEL III.7

Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section

Knowing the Facts About Medication Adherence Among Those with Serious Mental Illness

Transitioning a Pain Program Away From Chronic Opioid Prescribing

Prescription Drug Abuse

Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings

Brantford Native Housing Residential Support/ Addiction Treatment Program

Residential Substance Abuse Treatment: Impact of Concurrent Utilization Review

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma

This module will assist participants to:

General Hospital Information

SSTAR: 24 Years of Integrating Behavioral Health And Primary Care. Nancy Paull, MS LADC I CEO SSTAR/SSTAR of RI

U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health

May 21, 2015 Joint Committee on Finance Paper #352

Allyse Adams PC, LICDC Oriana House, Inc.

Treating Addiction in Chronic Pain Patients A Clinical Journey. Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest

Office-based Treatment of Opioid Dependence with Buprenorphine

FRN Research Report March 2011: Correlation between Patient Relapse and Mental Illness Post-Treatment

Jane Maxwell, UT Addiction Research Institute, Prescription Pain Medications and Heroin: A Changing Picture

OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines

Transcription:

West Virginia University School of Medicine BEHAVIORAL MEDICINE & PSYCHIATRY Morgantown, WV Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu Disclosure Reckitt Benckiser - speaker until 2014 A Group-Based Approach To Medication Assisted Treatment For Opioid Use Disorders: The West Virginia Model C.R. Sullivan, MD 1

History of Addiction Treatment 1964-1981 No primary addiction treatment 1981 Inpatient 28 day Minnesota Model - Residency training 1985 All MSIII on 2 week addiction rotation History of Addiction Treatment Early 1990 s Managed Care - Death of inpatient treatment in WV - Virtually no residential beds for addiction - No Day Programs for Substance Abuse Tx 1991 Addiction Intensive Outpatient Program History of Addiction Treatment Late 1990 s Prescription Opioid Epidemic in WV 30 million Americans suffer with chronic pain. Doctors are reluctant to prescribe opioids, thus 80% of those with chronic non-malignant pain go untreated as a result. New York Times, February, 22, 2002 C.R. Sullivan, MD 2

Annual Numbers of New Nonmedical Users of Pain Relievers: 1965-2002 Thousands of New Users All Ages Aged 18 or Older Aged Under 18 1965 1970 1975 1980 1985 1990 1995 2000 History of Addiction Treatment 2000 DATA; but where o where is buprenorphine? Opioid Dependence as a Hopeless Disease Considered starting methadone program History of Addiction Treatment 2002 Buprenorphine approved Jan 2003 We began to treat patients with buprenorphine 1/03-9/03 detoxification only C.R. Sullivan, MD 3

History of Addiction Treatment September 2003 Natalie M, first patient on MAT Late 2003 Huge demand and one physician! begins 2003 - No template for a clinic - Weekly medical and therapy groups - 4, 12-step mtgs/wk Medication alone is not enough All patients need medical and psychoeducational treatment C.R. Sullivan, MD 4

Medical and psycho-educational visits should always be tied together Provide as much structure as possible being mindful of cost/reimbursement Require attendance at 12-step programs Goal is abstinence from alcohol and drugs C.R. Sullivan, MD 5

Length of treatment 2004 -?? 2015 - indefinite 2015 > 2000 patients treated ~ 400 patients currently in clinic 60% female Average dose 12 mg Average time in clinic > 33 months Medicaid ~ 60% WV Medicaid Reimbursement 90853 - $18.09 group appointment 90834 - $54.54 (32-52 min) individual appt 90837 - $82.07 ( 52 min) 99213 - $35.92 med appointment C.R. Sullivan, MD 6

Currently 50 groups/week (medication + psycho-education) 4 Pregnancy groups/week ~ 35 patients 3 Telemedicine-buprenorphine groups/week Average group - 12 patients (Medicare limited to 10 patients) Outpatient intakes done by social work faculty, staff, students Labs, UDS, +/- review WVBOP at intake Review treatment agreement and sign *buprenorphine/nx given at time of intake if possible Each visit consists of : - 30 minute medical group - 60 minute psycho-educational group - random UDS dipstick on site that included buprenorphine (observed if necessary) - 12-step meeting list review Monthly individual appointment with therapist WV Medicaid requirement for 12 months C.R. Sullivan, MD 7

Structure Basic Group (weekly) < 90 days clean/sober On average takes 5 ½ months Intermediate (bi-weekly) 90 365 days Advanced (monthly) 1 year 3 years No Therapy (monthly) - > 3 years Medical Group Medication issues including dosage adjustments, side effects, film/tablet etc # of days clean Results of UDS 12-step group progress AA, NA, Celebrate Recovery, Bup Group etc Basic psychiatric progress No dual diagnosis treatment done Therapy Group *Build a sound recovery program Understanding the disease of addiction How buprenorphine works to support the process of recovery C.R. Sullivan, MD 8

Therapy Group Attendance and experience at 12 step meetings Identify triggers for relapse Develop and employ relapse prevention strategies Develop a supportive social network Trainees in Psychiatry residents Third year medical students Social work/counseling grad students Visiting Clinicians Administrative Meeting Bi-weekly 30 minute meeting of physicians, therapists, case managers and medical assistants Discuss current clinic issues, problems, etc Builds consistency and cohesion within the clinical treatment team. C.R. Sullivan, MD 9

Summary Medical and psychoeducational groups are tied together Active use of 12-step and community support groups Clinically efficient and cost effective way of engaging a larger number of patients in treatment Multi-disciplinary training Questions? C.R. Sullivan, MD 10